Brief: Medicenna Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
28/10/2022 12:09
Oct 28 (Reuters) - Medicenna Therapeutics Corp
MDNA.TO :
* MEDICENNA RECEIVES NASDAQ DEFICIENCY NOTICE REGARDING
MINIMUM
BID PRICE REQUIREMENT
Source text for Eikon: ID:nGNXbXJ8Cm
Further company coverage: MDNA.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicenna Therapeutics
See all newsBrief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results